港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

抗疫概念

976.811

+21.9542.30%

漲家數：17

跌家數：1

平家數：- -

市盈率：- -

高：984.418

開：954.770

低：954.770

收：954.857

資料載入中...

總覽新聞資訊

同源康醫藥-B盤中異動下午盤股價大跌6.45%報29.000港元

醫藥外包概念股集體走強維亞生物漲6.77% 機構指AI技術滲透加速CXO產業範式革新

稀缺科創生物醫藥新股！全球競爭優勢明顯，利潤3年翻了近四倍

徐冠巨代表：及時修訂《國民經濟行業分類》，納入新興產業

汽車價格戰暫停的信號，可能要來了？

Ofweek光电信息网

復星醫藥(02196)1類肺癌新藥申報上市顱內客觀緩解率可達100%

京東健康盤中異動早盤快速上漲3.10%

港股創新藥ETF漲超2.5%，來凱醫藥-B漲超11%，機構：具有高科技屬性的醫藥醫療公司將更受市場青睞

21世纪经济报道

港股異動 | 歌禮制藥-B(01672)漲超5% ASC30、ASC47均具備差異化設計方式產品發展未來可期

歌禮制藥-B盤中異動股價大漲5.14%

比亞迪電子盤中異動早盤股價大漲3.23%報52.800港元

《滬深》A股三大指數高開0.4%-0.6% 內房股偏好比亞迪高開

阿斯达克财经

金十數據整理：每日港股市場要聞速遞（3月6日週四）

白雲山(00874.HK)子公司獲頒高新技術企業證書可享內地企業優惠政策

阿斯达克财经

【中信建投：AI製藥潛力釋放，有望重塑醫藥未來圖景】中信建投研報表示，AI製藥領域正經歷着快速的迭代和變革，算法的更新迭代和算力的支持為AI在製藥領域的應用打下了良好的基礎。目前AI算法在臨牀前藥物發現階段已經有着深入且深刻的應用，海外頭部臨牀CRO公司在臨牀試驗中已經佈局AI多年，完全由AI研發的新藥有望在1-2年內成功上市。AI有望重塑藥物發現的模式，並且為製藥行業帶來潛移默化且持續地降本增效，驅動AI製藥管線和市場的快速增長，看好AI製藥行業長期的發展潛力及前景。

中信建投：AI製藥潛力釋放，有望重塑醫藥未來圖景

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1515/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":976.81055,"timestamp":1741248510324,"preClose":954.8568,"halted":0,"volume":575283040,"delay":0,"changeRate":0.022992,"change":21.953735,"pbRate":1.681623,"amount":5623531621,"amplitude":0.03105,"prevYearClose":787.97723,"fiveDayClose":966.408,"twentyDayClose":851.934,"turnoverRate":0.007641,"marketCap":671721238880,"floatMarketCap":554131605088,"peRate":21.189191},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":984.418,"amplitude":0.03105,"preClose":954.8568,"low":954.7698,"pbRate":"1.681623","latestPrice":976.81055,"volume":575283040,"delay":0,"open":954.7698,"prevYearClose":787.97723,"prevWeekClose":904.791,"prevMonthClose":904.791,"prevQuarterClose":787.977,"fiveDayClose":966.408,"twentyDayClose":851.934,"sixtyDayClose":807.806,"secType":"PLATE","market":"HK","turnoverRate":0.007641,"peRate":21.189191,"marketCap":671721238880,"floatMarketCap":554131605088,"timestamp":1741248510324,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":17,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:16,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517186478","title":"同源康醫藥-B盤中異動 下午盤股價大跌6.45%報29.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517186478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517186478?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 14:23","pubTimestamp":1741242194,"startTime":"0","endTime":"0","summary":"2025年03月06日下午盘14时23分，同源康医药-B股票出现波动，股价急速跳水6.45%。截至发稿，该股报29.000港元/股，成交量39.85万股，换手率0.11%，振幅9.52%。资金方面，该股资金流入665.168万港元，流出549.195万港元。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.51%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306142314abeada0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306142314abeada0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1515","BK1161","BK1574","09939"],"gpt_icon":0},{"id":"2517512188","title":"醫藥外包概念股集體走強 維亞生物漲6.77% 機構指AI技術滲透加速CXO產業範式革新","url":"https://stock-news.laohu8.com/highlight/detail?id=2517512188","media":"金吾资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517512188?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 13:48","pubTimestamp":1741240123,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药外包概念股集体走强，截至发稿，维亚生物 涨6.77%，康龙化成涨3.92%，泰格医药和药明康德涨3.24%，药明生物涨2.38%消息面上，国泰君安发布研报称，AI技术渗透加速CXO产业范式革新。AI技术在生物医药领域深度应用有望重构CXO产业价值链。全球药企降本增效诉求升级，叠加AI技术成熟度提升，驱动CXO企业加速智能化转型。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306134913963bb5f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306134913963bb5f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1515","BK1161","03347","09939","BK1574","02359","01873","BK1141","03759"],"gpt_icon":0},{"id":"2517092188","title":"稀缺科創生物醫藥新股！全球競爭優勢明顯，利潤3年翻了近四倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2517092188","media":"海豚音","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517092188?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 13:21","pubTimestamp":1741238460,"startTime":"0","endTime":"0","summary":"能否成为下一个生物医药趋势牛股，且看海豚今日为你深度剖析！微球第一股纳微科技采用耗材+仪器双轮驱动，除了色谱介质外还涉足分析色谱仪、平板显示用微球、体外诊断用微球等领域，相比之下赛分科技则主要聚焦于药物及生物大分子分离纯化液相色谱材料领域。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-03-06/doc-inenswii7959986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","BK1161","BK1574","09939","159938","000683.SH"],"gpt_icon":0},{"id":"2517904166","title":"徐冠巨代表：及時修訂《國民經濟行業分類》，納入新興產業","url":"https://stock-news.laohu8.com/highlight/detail?id=2517904166","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517904166?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 12:32","pubTimestamp":1741235521,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["09939","BK0239","BK1161","300832","159938","BK1574","BK1515"],"gpt_icon":0},{"id":"2517290987","title":"汽車價格戰暫停的信號，可能要來了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2517290987","media":"Ofweek光电信息网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517290987?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 11:11","pubTimestamp":1741230660,"startTime":"0","endTime":"0","summary":"而提交的5个议案中，只有关于优化新能源车号牌设计的建议出圈，拿下了多数关注。目前2025年关于汽车的相关提案，能提炼出的关键词是，希望全力推进自动驾驶。而2023年，也是汽车价格战真正开打的元年，以雪铁龙C6大降价为真正引爆点的大降价行为，本身是燃油车面对新能源车时竞争力明显下降，落后产能急于出清。从价格战，切换到技术战的信号，已经非常明显。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306112810989e01fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306112810989e01fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015978.USD","BK1515","LU0449515922.USD","LU0516423174.USD","LU0511384066.AUD","LU0516422366.SGD","LU1868838027.USD","BK1607","BK1540","LU1808992512.USD","LU0054450605.USD","BK1522","LU0274383008.USD","00285","LU2097828805.USD","LU0856984785.SGD","LU2097828631.EUR","002594","BK1119","01211","LU0417516738.SGD","LU0348766576.USD","BK1610","LU0708995583.HKD","BYDDY","LU0320764599.SGD","LU0823426308.USD","LU1023057109.AUD","SG9999006597.SGD","LU1861214812.USD","LU0819123356.HKD","HYDD.SI","LU0254981946.USD","LU0307460666.USD","LU2476274308.USD","LU1242518857.USD","LU2348774022.SGD","LU0359202008.SGD","81211","BK1589","BK1509","LU0143863198.USD","LU0593848301.USD","LU0449509016.USD","SG9999015945.SGD","LU0516422952.EUR","LU2778985437.USD","LU2360107325.USD","BK1504","BK1580"],"gpt_icon":1},{"id":"2517051689","title":"復星醫藥(02196)1類肺癌新藥申報上市 顱內客觀緩解率可達100%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517051689","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517051689?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 10:55","pubTimestamp":1741229701,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月6日，中国国家药监局药品审评中心官网最新公示，复星医药成员企业复星万邦申报的1类新药丁二酸复瑞替尼胶囊的上市申请获得受理。在该研究中，复瑞替尼治疗基线脑转移的ALK阳性晚期NSCLC患者，颅内客观缓解率可达到100%。图片来源：CDE官网根据复星医药此前公布的研究结果，从2020年12月至2022年3月，该研究共招募275例患者，其中139例接受复瑞替尼治疗，136例接受对照药治疗。截至2024年3月，中位随访时间为16.7个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258393.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0196","BK0187","BK0060","BK0188","BK1515","BK0012","BK0028","600196","BK0096","BK0183","BK1593","02196","BK0239","BK1191","BK0175"],"gpt_icon":0},{"id":"2517055009","title":"京東健康盤中異動 早盤快速上漲3.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517055009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517055009?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 10:50","pubTimestamp":1741229447,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘10时50分，京东健康股票出现异动，股价大幅上涨3.10%。截至发稿，该股报39.850港元/股，成交量1228.75万股，换手率0.38%，振幅4.53%。京东健康股票所在的药品分销行业中，整体涨幅为0.36%。其相关个股中，叮当健康、大健康国际、京东健康涨幅较大，振幅较大的相关个股有叮当健康、金活医药集团、澳至尊，振幅分别为5.15%、4.88%、4.82%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306105047abea8f94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306105047abea8f94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1591","BK1589","06618","BK1583","LU0456827905.SGD","BK1515","LU0051755006.USD","BK1247","BK1142","86618","BK1571"],"gpt_icon":0},{"id":"2517055799","title":"港股創新藥ETF漲超2.5%，來凱醫藥-B漲超11%，機構：具有高科技屬性的醫藥醫療公司將更受市場青睞","url":"https://stock-news.laohu8.com/highlight/detail?id=2517055799","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517055799?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 10:35","pubTimestamp":1741228542,"startTime":"0","endTime":"0","summary":"相关ETF方面，港股创新药ETF截至发稿涨2.52%，成交额超1亿元，换手率超20%，盘中交投活跃。港股创新药ETF紧密跟踪港股通创新药指数，该指数反映港股通生物科技产业上市公司的运行特征。财通证券表示，看多创新药政策新周期带来的产业链共振上升，看多AI对医药产业带来的中长期影响，具有高科技属性的医药医疗公司将更受市场青睐。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306104204a261a137&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306104204a261a137&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02105","09939","BK1515"],"gpt_icon":0},{"id":"2517908031","title":"港股異動 | 歌禮制藥-B(01672)漲超5% ASC30、ASC47均具備差異化設計方式 產品發展未來可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2517908031","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517908031?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 10:22","pubTimestamp":1741227746,"startTime":"0","endTime":"0","summary":"中信建投发布研报称，歌礼制药-B发布公告，其GLP-1R激动剂ASC30在美国Ib期临床试验取得积极成果。数据显示，前两个列队中ASC30经安慰剂组校准后分别使体重下降4.2%和6.2%，并且安全性良好。该行认为，全球减重药物市场规模蓬勃成长，众多超重或肥胖成年人群急需创新药物来改善并提高生活质量，在此基础下，公司的两款药物ASC30、ASC47均具备差异化设计方式，产品发展未来可期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258377.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1515","01477","BK1161","BK1574","01672"],"gpt_icon":0},{"id":"2517908542","title":"歌禮制藥-B盤中異動 股價大漲5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517908542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517908542?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 10:19","pubTimestamp":1741227599,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘10时19分，歌礼制药-B股票出现波动，股价急速上涨5.14%。截至发稿，该股报7.360港元/股，成交量325.1万股，换手率0.34%，振幅5.29%。资金方面，该股资金流入953.631万港元，流出1142.22万港元。歌礼制药-B股票所在的生物技术行业中，整体涨幅为2.00%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306102000a261980a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306102000a261980a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1515","01672","01477","BK1161","BK1191"],"gpt_icon":0},{"id":"2517977337","title":"比亞迪電子盤中異動 早盤股價大漲3.23%報52.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517977337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517977337?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 09:30","pubTimestamp":1741224611,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘09时30分，比亚迪电子股票出现波动，股价大幅上涨3.23%。截至发稿，该股报52.800港元/股，成交量30.3万股，换手率0.01%，振幅1.86%。资金方面，该股资金流入381.55万港元，流出201.95万港元。比亚迪电子股票所在的电讯设备行业中，整体涨幅为0.51%。其相关个股中，鸿腾精密、中兴通讯、环联连讯涨幅较大，振幅较大的相关个股有环联连讯、长飞光纤光缆、比亚迪电子，振幅分别为3.27%、2.77%、1.66%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306093011963b724e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306093011963b724e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348767384.USD","BK1504","BK1149","LU0348766576.USD","LU0274383008.USD","BK1607","BK1589","00285","BK1580","BK1540","BK1582","BK1515"],"gpt_icon":0},{"id":"2517977147","title":"《滬深》A股三大指數高開0.4%-0.6% 內房股偏好 比亞迪高開","url":"https://stock-news.laohu8.com/highlight/detail?id=2517977147","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517977147?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 09:29","pubTimestamp":1741224540,"startTime":"0","endTime":"0","summary":"人民银行今日公开市场开展1,045亿元人民币(下同)7天期逆回购操作，操作利率持平于1.5%。今日有2,150亿元逆回购到期，单日净回笼1,105亿元。人民币兑美元中间价报7.1692，上调22点。A股三大指数高开。沪指高开11点或0.4%，开报3,353点。深成指报10,774点，高开64点或0.6%。创业板指高开13点或0.6%，开报2,204点。内银股工行建行分别低开0.3%及0.2%。国际油价下跌，中石油及中海油各低开0.8%。此外，比亚迪高开1.8%。宁德时代高开0.5%。(A股报价延迟最少十五分钟。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180419151914120_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180419151914120_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/analysis/china-hot-topic-content.aspx?id=NOW.1422557&catg=4&source=AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2097828474.EUR","LU0588546209.SGD","BK1589","LU2328871848.SGD","BK0155","BK0188","LU1861219969.SGD","SG9999002463.SGD","LU0143863784.USD","LU1242518857.USD","HYDD.SI","SG9999014674.SGD","LU0214875030.USD","LU0054450605.USD","LU0211977185.USD","LU0254981946.USD","LU0348805143.USD","BK0072","LU2580892789.USD","LU0516422952.EUR","00285","BK1539","LU1868837722.USD","SG9999001226.SGD","BK1515","LU0289739343.SGD","LU1969619763.USD","BYDDY","LU0516423174.USD","LU0856984785.SGD","BK1509","159982","399300","BK0183","EVS.SI","LU0348767384.USD","LU0516422366.SGD","LU0516423091.SGD","LU2348774022.SGD","81211","LU0511384066.AUD","002594","BK0014","LU0531970944.HKD","LU0819121731.USD","LU2249611893.SGD","LU0320764599.SGD","LU2476274308.USD","LU2097828631.EUR","01211"],"gpt_icon":1},{"id":"2517697100","title":"金十數據整理：每日港股市場要聞速遞（3月6日 週四）","url":"https://stock-news.laohu8.com/highlight/detail?id=2517697100","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517697100?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 09:06","pubTimestamp":1741223183,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["IE00B0169L03.USD","BK1539","03143","BK1594","HK0000306701.USD","HSTECH","LU0072913022.USD","BK0188","IE0034224299.USD","BK1549","LU2778985437.USD","01519","09888","00182","00732","BK1515","HSCEI","YANG","BIDU","00305","LU0501845795.SGD","BK4543","01093","LU0708995583.HKD","SG9999006597.SGD","LU2039709279.SGD","07226","01288","LU0314109678.HKD","LU1497733557.USD","03347","03900","00884","IE00B19Z5X02.USD","LU2328871848.SGD","01918","LU0052750758.USD","BEST","LU1226288253.USD","601288","02380","IE00B0JY6N72.USD","IE0008368742.USD","LU0287142896.SGD","IE00B5MMRT66.SGD","LU0359202008.SGD","00220","89888","BK4502","LU1152091754.HKD"],"gpt_icon":1},{"id":"2517971082","title":"白雲山(00874.HK)子公司獲頒高新技術企業證書 可享內地企業優惠政策","url":"https://stock-news.laohu8.com/highlight/detail?id=2517971082","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517971082?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 08:53","pubTimestamp":1741222380,"startTime":"0","endTime":"0","summary":"白云山(00874.HK) 公布，旗下子公司广药总院已通过高新技术企业重新认定，并收到由广东省科学技术厅、广东省财政厅、国家税务总局广东省税务局联合颁发的《高新技术企业证书》，公告指，广药总院通过高新技术企业认定后，根据国家的相关规定，自获得高新技术企业认定后连续三年内可享受国家关于高新技术企业的相关优惠政策，即按15%的税率缴纳企业所得税。另外，白云山去年已按照15%的所得税税率计缴该公司所得税。本次广药总院获得《高新技术企业证书》不会对白云山当期经营业绩产生重大影响。(js/w)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-05 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190128164618458_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190128164618458_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1422532/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0070","BK1191","BK0183","BK0188","BK1515","BK0175","BK1197","BK0028","BK0096","600332","00874","BK0196","BK1521","BK0097","BK1606","BK0239","BK0012"],"gpt_icon":0},{"id":"2517979350","title":"【中信建投：AI製藥潛力釋放，有望重塑醫藥未來圖景】中信建投研報表示，AI製藥領域正經歷着快速的迭代和變革，算法的更新迭代和算力的支持為AI在製藥領域的應用打下了良好的基礎。目前AI算法在臨牀前藥物發現階段已經有着深入且深刻的應用，海外頭部臨牀CRO公司在臨牀試驗中已經佈局AI多年，完全由AI研發的新藥有望在1-2年內成功上市。AI有望重塑藥物發現的模式，並且為製藥行業帶來潛移默化且持續地降本增效，驅動AI製藥管線和市場的快速增長，看好AI製藥行業長期的發展潛力及前景。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517979350","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517979350?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 08:24","pubTimestamp":1741220695,"startTime":"0","endTime":"0","summary":"中信建投研报表示，AI制药领域正经历着快速的迭代和变革，算法的更新迭代和算力的支持为AI在制药领域的应用打下了良好的基础。目前AI算法在临床前药物发现阶段已经有着深入且深刻的应用，海外头部临床CRO公司在临床试验中已经布局AI多年，完全由AI研发的新药有望在1-2年内成功上市。AI有望重塑药物发现的模式，并且为制药行业带来潜移默化且持续地降本增效，驱动AI制药管线和市场的快速增长，看好AI制药行业长期的发展潜力及前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06082448553034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["03347","01477","09939","BK1583","BK0276","BK1161","BK1515","159938","BK1191","BK1141","BK1574","BK1576","601066"],"gpt_icon":0},{"id":"2517976961","title":"中信建投：AI製藥潛力釋放，有望重塑醫藥未來圖景","url":"https://stock-news.laohu8.com/highlight/detail?id=2517976961","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517976961?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 08:16","pubTimestamp":1741220177,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1574","BK0276","BK1141","159938","03347","BK1583","BK1161","BK1576","601066","09939","BK1191","01477","BK1515"],"gpt_icon":0}],"pageSize":16,"totalPage":37,"pageCount":4,"totalSize":583}]}}